{
    "2018-11-29": [
        [
            {
                "time": "",
                "original_text": "两市跌幅再扩大 外资猛抄滞涨股(名单)",
                "features": {
                    "keywords": [
                        "两市",
                        "跌幅",
                        "外资",
                        "滞涨股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "北向资金月内净流入超400亿创6个月新高 外资抄底滞涨股（名单）",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净流入",
                        "外资",
                        "抄底",
                        "滞涨股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【医药徐佳熹】医药生物行业2019年投资策略报告——新游戏规则 vs 历史的轮回",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "行业",
                        "投资策略",
                        "新游戏规则",
                        "历史轮回"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}